Beam Therapeutics's market cap is currently $2.77B. The company's EPS TTM is $-1.76; its P/E ratio is ―; Beam Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 377.71M	$ 60.92M	$ 51.84M	$ 24.00K	$ 18.00K
Gross Profit	$ -59.67M	$ 38.34M	$ 35.40M	$ -103.16M	$ -5.39M
Operating Income	$ -176.49M	$ -338.48M	$ -392.46M	$ -132.76M	$ -75.15M
EBITDA	$ -156.47M	$ -324.33M	$ -392.46M	$ -128.03M	$ -71.65M
Net Income	$ -132.53M	$ -263.59M	$ -341.36M	$ -256.42M	$ -78.44M
Balance Sheet
Cash & Short-Term Investments	$ 1.19B	$ 1.08B	$ 965.65M	$ 299.67M	$ 91.85M
Total Assets	$ 1.46B	$ 1.34B	$ 1.47B	$ 451.68M	$ 156.10M
Total Debt	$ 172.69M	$ 179.00M	$ 142.35M	$ 100.23M	$ 25.52M
Net Debt	$ -263.21M	$ -53.76M	$ -823.30M	$ -61.94M	$ -11.70M
Total Liabilities	$ 478.38M	$ 608.24M	$ 647.72M	$ 206.12M	$ 55.15M
Stockholders' Equity	$ 981.33M	$ 733.47M	$ 826.74M	$ 245.56M	$ 100.94M
Cash Flow
Free Cash Flow	$ -182.93M	$ -26.42M	$ -113.08M	$ -112.10M	$ -84.52M
Operating Cash Flow	$ -149.19M	$ 22.53M	$ -66.27M	$ -95.74M	$ -72.00M
Investing Cash Flow	$ 71.84M	$ -461.34M	$ -294.14M	$ -100.12M	$ -66.66M
Financing Cash Flow	$ 276.45M	$ 111.59M	$ 756.14M	$ 322.32M	$ 41.28M

Currency in USD

Beam Therapeutics Earnings and Revenue History

Income Statement >

Beam Therapeutics Debt to Assets

Balance Sheet >

Beam Therapeutics Cash Flow

Cash Flow >

Beam Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing